The lawsuits also noted one dinner for three, including the speaker, at a Washington DC restaurant which cost over $2,000. At another programme held on Valentine’s Day in 2006, Novartis paid $3,127 for a meal for two, while the DoJ also cites data which shows that during January 2002 to November 2011, nearly $65 million was spent and more than 38,000 speaker programmes were conducted for the three aforementioned drugs.
In September 2010, the company signed a corporate integrity agreement with US authorities agreeing to implement a rigorous compliance programme. This was agreed after Novartis paid $422.5 million to settle allegations that it marketed the epilepsy drug Trileptal (oxcarbazepine) and five other drugs for unauthorised use in the USA.
No comments:
Post a Comment